http://www.eurekalert.org/pub_releases/2016-03/ifqa-aim030116.php
Aflibercept (trade name: Eylea) has been approved since October 2015 for adults with impaired vision due to myopic choroidal neovascularisation.
The drug has already undergone several early benefit assessments according...
